Antibodies for molecular imaging in the cardiovascular system

Journal of Nuclear Cardiology

Volumn 12, Issue 5, 2005, Pages 591-604

  Khaw, Ban An ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; EDRECOLOMAB; IMMUNOGLOBULIN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN M ANTIBODY; INDIUM 111; IODINE 131; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2G42D7; MONOCLONAL ANTIBODY R11D10; MONOCLONAL ANTIBODY Z2D3; MYOSIN ANTIBODY; MYOSIN ANTIBODY IN 111; PENTETATE TECHNETIUM TC 99M; POLYCLONAL ANTIBODY; POLYMER; PYROPHOSPHATE TECHNETIUM TC 99M; RADIOISOTOPE; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANTIBODY LABELING; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR SYSTEM; DIAGNOSTIC IMAGING; HEART TRANSPLANTATION; HUMAN; ISOTOPE LABELING; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 25444526101     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2005.07.001     Document Type: Review

References (75)

1. D. Pressman G. Keighley Zone of activity of antibodies as determined by use of radioactive tracers: Zone of activity of nephritoxic antikidney serum J Immunol 59 1948 141-146
2. B.A. Khaw G.A. Beller E. Haber T.W. Smith Localization of cardiac myosin-specific antibody in myocardial infarction J Clin Invest 58 1976 439-446
3. 111In monoclonal antibody specific for tenascin-C Circulation 106 2002 1397-1402
4. G.E.R. Weller E. Lu M.M. Csikari A.L. Klibanov D. Fischer W.R. Wagner et al. Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1 Circulation 108 2003 218-224
5. B.A. Khaw J. Scott J.T. Fallon E. Haber C. Homcy Myocardial injury: quantitation by cell sorting initiated with anti-myosin fluorescent spheres Science 217 1982 1050-1053
6. B.A. Khaw G.A. Beller E. Haber T.W. Smith Localization of cardiac myosin-specific antibody in myocardial infarction J Clin Invest 58 1976 439-446
7. G.A. Beller B.A. Khaw E. Haber T.W. Smith Localization of radiolabeled cardiac myosin-specific antibody in myocardial infarctions: Comparison with technetium 99-m stannous pyrophosphate Circulation 55 1977 74-78
8. B.A. Khaw H.W. Strauss G.M. Pohost J.T. Fallon E. Katus HA Haber The relationship of immediate and delayed thallium-201 distribution to localization of I-125-antimyosin antibody in acute experimental myocardial infarction Am J Cardiol 51 1983 1428-1432
9. B.A. Khaw J.T. Fallon H.W. Strauss E. Haber Myocardial infarct imaging with indium-111-diethylene triamine pentaacetic acid-anticanine cardiac myosin antibodies Science 209 1980 295-297
10. B.A. Khaw H.W. Strauss A. Carvalho E. Locke H.K. Gold E. Haber Technetium-99m labeling of antibodies to cardiac myosin Fab and to human fibrinogen J Nucl Med 23 1982 1011-1019
11. B.A. Khaw J.A. Mattis G. Melincoff H.W. Strauss H.K. Gold E. Haber Monoclonal antibody to cardiac myosin: Imaging of experimental myocardial infarction Hybridoma 3 1984 11-23
12. B.A. Khaw A. Petrov J. Narula Complementary roles of antibody affinity and specificity in in vivo diagnostic cardiovascular targeting: How specific is antimyosin for irreversible myocardial damage? J Nucl Cardiol 6 1999 316-323
13. J.F.R. Kerr A.H. Wyllie A.R. Currie Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics Br J Cancer 26 1972 239-257
14. T. Shirai CommentTry: Oncosis and apoptosis: two faces of necrosis in a new proposal to clear up the confusion regarding cell death Toxicol Pathol 27 1999 495-496
15. J. Narula N. Haider R. Virmani T.G. DiSalvo F.D. Kolodgie R.J. Hajjar et al. Programmed myocyte death in end-stage heart failure N Engl J Med 335 1996 1182-1189
16. R.P. Laguens P.M. Meckert J.S. Martino S. Perrone R. Favaloro Identification of programmed cell death (apoptosis) in situ by means of specific labeling of nuclear DNA fragments in heart biopsy samples during acute rejection episodes J Heart Lung Transplant 15 1996 911-918
17. B.A. Khaw J. da Silva A. Petrov W. Hartner In-111 antimyosin and Tc-99m glucaric acid for non-invasive identification of oncotic and apoptotic myocardial necrosis J Nucl Cardiol 9 2002 471-481
18. B.A. Khaw H.K. Gold T. Yasuda R.C. Leinbach M. Kanke J.T. Fallon et al. Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin specific antibody Circulation 74 1986 501-508
19. K.Y. Pak M.A. Nedelman M. Kanke B.A. Khaw J.A. Mattis H.W. Strauss et al. An instant method for labeling antimyosin Fab' with technetium-99m: evaluation in an experimental myocardial infarct model J Nucl Med 33 1992 144-149
20. J. Rousseau H.M. Sikorska A. Gervais G. Bisson P. Margaron G. Lamoureux et al. Evaluation of a 99mTc-antimyosin kit for myocardial infarct imaging J Nucl Biol Med 38 Suppl 1 1994 43-53
21. R. Taillefer L. Boucher R. Lambert J. Gregoire D.C. Phaneuf H. Sikorsa Technetium-99m antimyosin antibody(3-48) myocardial imaging: Human biodistribution, safety and clinical results in detection of acute myocardial infarction Eur J Nucl Med 22 1995 453-464
22. R. Senior S. Battacharya R. Manspeaker X.J. Liu J.A. Leppo A. Lahiri 99mTc-antimyosin antibody imaging for the detection of acute myocardial infarction in human beings Am Heart J 126 1993 536-542
23. B.A. Khaw T. Yasuda H.K. Gold R.C. Leinbach J.A. Johns M. Kanke et al. Acute myocardial infarct imaging with indium-111-labeled monoclonal antimyosin Fab J Nucl Med 28 1987 1671-1678
24. L.L. Johnson D.W. Seldin L.C. Becker N.D. LaFrance H.A. Liberman C. James et al. Antimyosin imaging in acute transmural myocardial infarctions: Results of a multicenter clinical trial J Am Coll Cardiol 13 1989 27-35
25. 99mTc-fibrinogen [abstract] Clin Res 29 1981 496
26. W.H. Frist T. Yasuda I.R. McDougal G. Segal B.A. Khaw H.W. Strauss et al. Noninvasive detection of human cardiac transplant rejection with In-111 antimyosin (Fab) imaging [abstract] Circulation 74 Suppl II 1986 219
27. W.H. Frist G. Segal T. Yasuda I.R. McDougal B.A. Khaw E. Haber Cardiac transplant rejection and In-111 antimyosin imaging [abstract] Clin Nucl Med 2 1986 B9
28. W. Frist T. Yasuda G. Segall B.A. Khaw H.W. Strauss H.K. Gold et al. Noninvasive detection of human cardiac transplant rejection with indium-111 antimyosin (Fab) imaging Circulation 76 1987 V81-V85
29. T. Hall W.A. Baumgartner A.M. Borkon N.D. LaFrance T.A. Traill S. Norris et al. Diagnosis of acute cardiac rejection with antimyosin monoclonal antibody, phosphorous nuclear magnetic resonance imaging, two-dimensional echocardiography, and endocardial biopsy J Heart Transplant 5 1986 419-424
30. 111In-antimyosin Eur J Nucl Med 13 1987 343-347
31. L.J. Addonizio R.E. Michler C. Marboe P.E. Esser L.L. Johnson D.W. Seldin et al. Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab J Am Coll Cardiol 9 1987 555-564
32. M. Isobe E. Haber B.A. Khaw Early detection of rejection and assessment of cyclosporine therapy by indium-111 antimyosin imaging in mouse heart allografts Circulation 84 1991 1246-1255
33. T. Nishimura M. Sada H. Sasaki C. Yutani T. Fujita H. Amemiya et al. Assessment of severity of cardiac rejection in heterotopic heart transplantation using indium-111 antimyosin and magnetic resonance imaging Cardiovasc Res 22 1988 108-112
34. M.D. Allen Y. Shoji Y. Fujimura J.F. Eary D.D. Reichenbach R. Thomas et al. Effect of cyclosporine on the uptake of monoclonal antibody to cardiac myosin J Heart Lung Transplant 10 1991 775-781
35. K. Takeda K. Ueda U. Scheffel H. Ravert N.D. LaFrance W.A. Baumgartner et al. Indium-111 myosin-specific antibodies and technetium-99m pyrophosphate in the detection of acute cardiac rejection of transplanted hearts: Studies in a heterotopic rat heart model Eur J Nucl Med 18 1991 461-466
36. M. Billingham Endomyocardial biopsy detection of acute rejection in cardiac allograft recipients Heart Vessels Suppl 1 1985 86-90
37. M. Ballester D. Obrador I. Carrio J.M. Caralps-Riera Indium-111 monoclonal antimyosin antibody studies in the diagnosis of rejection and management of patients after heart transplantation In: B.A. Khaw J. Narula H.W. Strauss editors. Monoclonal antibodies in cardiovascular diseases 1994 Lea & Febiger Philadelphia 79-98
38. M. Ballester-Rodes I. Carrio-Gasset M.L. Abadal-Berini D. Obrador-Mayol L. Berna-Roqueta J.M. Caralps-Riera Patterns of evolution of myocyte damage after human heart transplantation detected by indium-111 monoclonal antimyosin Am J Cardiol 62 1988 623-627
39. M. Ballester D. Obrador I. Carrio C. Moya J.M. Auge R. Bordes et al. Early postoperative reduction of monoclonal antimyosin antibody uptake is associated with the absent rejection-related complications after heart transplantation Circulation 85 1992 61-68
40. J.M. Latre J.M. Arizon A. Jimenez-Heffernan M. Anguita F.M. Gonzalez F.L. Rubio et al. Noninvasive radioisotope diagnosis of acute heart rejection J Heart Lung Transplant 11 1992 453-456
41. D. De Nardo G. Scibilia A.G. Macchiarelli A. Cassisi E. Tonelli U. Papalia et al. The role of indium-111 antimyosin (Fab) imaging as a noninvasive surveillance method of human heart transplant rejection J Heart Transplant 8 1989 407-412
42. A. Schuetz S. Fritsch B.M. Kemkes C. Fugler C. Angermann C. Spes et al. Antimyosin monoclonal antibodies for early detection of cardiac allograft rejection J Heart Transplant 9 1990 654-661
43. J.W. Mason M.E. Billingham D.R. Ricci Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy Am J Cardiol 45 1980 1037-1044
44. T. Yasuda I.F. Palacios G.W. Dec J.T. Fallon H.K. Gold R.C. Leinbach et al. Indium-111 monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis Circulation 76 1987 306-311
45. J. Narula B.A. Khaw T. Yasuda Antimyosin imaging for acute myocarditis In: B.A. Khaw J. Narula H.W. Strauss editors. Monoclonal antibodies in cardiovascular diseases 1993 Lea & Febiger Philadelphia 67-78
46. G.W. Dec I. Palacios T. Yasuda J.T. Fallon B.A. Khaw H.W. Strauss et al. Antimyosin antibody cardiac imaging: Its role in the diagnosis of myocarditis J Am Coll Cardiol 16 1990 97-104
47. I. Carrio L. Berna M. Ballester M. Estorch D. Obrador M. Cladellas et al. Indium-111 antimyosin scintigraphy to assess myocardial damage in patients suspected of myocarditis and cardiac rejection J Nucl Med 29 1988 1893-1900
48. D. Obrador M. Ballester I. Carrio J.M. Auge C.M. Lopez I. Bosch et al. Active myocardial damage without attending inflammatory response in dilated cardiomyopathy J Am Coll Cardiol 21 1993 1667-1671
49. U. Kuhl B. Lauer M. Souvatzoglu H. Vosberg H.P. Schultheiss Antimyosin scintigraphy and immunohistologic analysis of endomyocardial biopsy in patients with clinically suspected myocarditis-evidence of myocardial cell damage and inflammation in the absence of histologic signs of myocarditis J Am Coll Cardiol 32 1998 1371-1376
50. J. Narula J.F. Southern G.W. Dec I.F. Palacios J.B. Newell J.T. Fallon et al. Antimyosin uptake and myofibrillarlysis in dilated cardiomyopathy J Nucl Cardiol 2 1995 470-477
51. J. Narula N. Haider R. Virmani T.G. DiSalvo F.D. Kolodgie R.J. Hajjar et al. Programmed myocyte death in end-stage heart failure N Engl J Med 335 1996 1182-1189
52. I. Casans A. Villar V. Almenar A. Blanes Lyme carditis diagnosed by indium-111-antimyosin antibody scintigraphy Eur J Nucl Med 15 1989 330-331
53. J. Bergler-Klein H. Sochor G. Stanek S. Globits R. Ullrich D. Glogar In 111-monoclonal antimyosin antibody and magnetic resonance imaging in the diagnosis of acute Lyme myopericarditis Arch Intern Med 153 1993 2696-2700
54. 111in-labeled antimyosin in Churg-Strauss vasculitis with myocardial involvement Nuklearmedizin 29 1990 177-179
55. A.J. Morguet D. Sandrock M. Stille-siegener H.R. Figulla Indium-111-antimyosin Fab imaging to demonstrate myocardial involvement in systemic lupus erythematosus J Nucl Med 36 1995 1432-1435
56. J. Narula A. Malhotra T. Yasuda K.K. Talwar K.S. Reddy P. Chopra et al. Usefulness of antimyosin antibody imaging for the detection of active rheumatic myocarditis Am J Cardiol 84 1999 946-950
57. M. Estorch I. Carrio L. Berna C. Martinez-Duncker C. Alonso J.R. Germa et al. 111In-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer J Nucl Med 31 1990 1965-1970
58. A. Doria Y. Sherer P.L. Meroni Y. Schoenfeld Inflammation and accelerated atherosclerosis: Basic mechanisms Rheum Dis Clin North Am 31 2005 355-362
59. D.R. Hathaway K.L. March Molecular cardiology: New avenues for the diagnosis and treatment of cardiovascular disease J Am Coll Cardiol 13 1989 265-282
60. J.R. Davies J.H. Rudd P.L. Weissberg Molecular and metabolic imaging of atherosclerosis J Nucl Med 45 2004 1898-1907
61. 99mTc S12 antibody imaging of platelet alpha granules in rabbit endothelial neointimal proliferation after angioplasty Circulation 83 1991 224-236
62. M. Ciavolella R. Tavolaro M. Taurino M. Di Loreto C. Greco E. Sbarigia et al. Immunoscintigraphy of atherosclerotic uncomplicated lesions in vivo with a monoclonal antibody against D-dimer of insoluble fibrin Atherosclerosis 143 1999 171-175
63. C.M. Matter P.K. Schuler P. Alessi P. Meier R. Ricci D. Zhang et al. Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin Circ Res 95 2004 1225-1233
64. S. Tsimikas W. Palinski S.E. Halpern D.W. Yeung L.K. Curtis J.L. Witztum Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo J Nucl Cardiol 6 1999 41-53
65. S. Tsimikas Noninvasive imaging of oxidized low-density lipoprotein in atherosclerotic plaques with tagged oxidation-specific antibodies Am J Cardiol 90 2002 22L-27L
66. J.W. Choi D.J. Kim J.H. Rhim J.H. Chung H.K. Chung Generation and characterization of IgG monoclonal antibodies specific for malondialdehyde Hybrid Hybridomics 22 2003 259-262
67. D.C. Harrison E. Calenoff F. Chen W. Parmley B.A. Khaw R. Ross Plaque-associated immune reactivity as a tool for the diagnosis and treatment of atherosclerosis Trans Am Clin Climatol Assoc 103 1992 210-217
68. J. Narula A. Petrov C. Bianchi C.C. Ditlow J. Dilley I. Pieslak et al. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 antibody specific for the proliferating smooth muscle cells of human atheroma: Imaging with conventional antibody and image enhancement with negative charge-modified antibody Circulation 92 1995 474-484
69. C.C. Ditlow F.W. Chen E. Calenoff Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof 1998 US patent 5,811,248. Sep 22
70. J. Narula C. Ditlow F. Chen B.A. Khaw Monoclonal antibodies for the detection of atherosclerotic lesions In: B.A. Khaw J. Narula H.W. Strauss editors. Monoclonal antibodies in cardiovascular diseases 1993 Lea & Febiger Philadelphia 206-215
71. J. Narula A. Petrov C. Bianchi C.C. Ditlow J. Dilley I. Pieslak et al. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 antibody specific for the proliferating smooth muscle cells of human atheroma: Imaging with conventional antibody and image enhancement with negative charge-modified antibody Circulation 92 1995 474-484
72. J. Narula A. Petrov C. Ditlow K.Y. Pak F.W. Chen B.A. Khaw Maximizing radiotracer delivery for scintigraphic localization of experimental atherosclerotic lesions with high-dose negative-charge-modified Z2D3 antibody J Nucl Cardiol 4 1997 226-233
73. I. Carrió P.L. Pieri J. Narula L. Prat P. Riva L. Pedrini et al. Noninvasive localization of human atherosclerotic lesions with In-111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells J Nucl Cardiol 5 1998 551-557
74. -/- mice: Use of bispecific antibody and Tc-99m-labeled polymeric probes 2005 Presented at the International Conference on Nuclear Cardiology. Lisbon, Portugal; 7. May 8-11
75. B.A. Khaw A. Klibanov S.M. O'Donnell T. Siato N. Nossiff M.A. Slinkin et al. Gamma imaging with negatively charge-modified monoclonal antibody: modification with synthetic polymers J Nucl Med 32 1991 1742-1751